The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Exosome Therapeutics and Diagnostics Market Research Report 2025

Global Exosome Therapeutics and Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1955753

No of Pages : 105

Ask Your Query
Synopsis
Exosomes are small vesicles secreted by cells, which contain biomolecules such as proteins, nucleic acids, and lipids. In recent years, exosomes have attracted much attention due to their role in intercellular communication, disease occurrence and development, etc. The application of exosomes in treatment and diagnosis has also gradually attracted attention.
The global Exosome Therapeutics and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Exosome Therapeutics and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Therapeutics and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Exosome Therapeutics and Diagnostics in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Exosome Therapeutics and Diagnostics include Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, Mantra Bio, Adipomics, ReNeuron, Aegle Therapeutics, Sarepta Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapeutics and Diagnostics.
The Exosome Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Evox Therapeutics
Carmine Therapeutics
Exopharm
Aruna Bio
Capricor Therapeutics
Mantra Bio
Adipomics
ReNeuron
Aegle Therapeutics
Sarepta Therapeutics
Codiak Biosciences
Exosomics
Innocan Pharma
Aethlon Medical
ExoCoBio
Organicell
Puretech
Versatope
Vesvigen Therapeutics
Exosome Plus
Exosome Diagnostics
ECHO Biaotech
Segment by Type
Treatment
Diagnosis
Segment by Application
Cancer
Neurological Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Therapeutics and Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Treatment
1.2.3 Diagnosis
1.3 Market by Application
1.3.1 Global Exosome Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Neurological Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapeutics and Diagnostics Market Perspective (2019-2030)
2.2 Global Exosome Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Exosome Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Exosome Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Exosome Therapeutics and Diagnostics Market Dynamics
2.3.1 Exosome Therapeutics and Diagnostics Industry Trends
2.3.2 Exosome Therapeutics and Diagnostics Market Drivers
2.3.3 Exosome Therapeutics and Diagnostics Market Challenges
2.3.4 Exosome Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Exosome Therapeutics and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Exosome Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Exosome Therapeutics and Diagnostics Revenue
3.4 Global Exosome Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Exosome Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapeutics and Diagnostics Revenue in 2023
3.5 Global Key Players of Exosome Therapeutics and Diagnostics Head office and Area Served
3.6 Global Key Players of Exosome Therapeutics and Diagnostics, Product and Application
3.7 Global Key Players of Exosome Therapeutics and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Exosome Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)
5 Exosome Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Exosome Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Therapeutics and Diagnostics Market Size (2019-2030)
6.2 North America Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
6.4 North America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Therapeutics and Diagnostics Market Size (2019-2030)
7.2 Europe Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.4 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapeutics and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Therapeutics and Diagnostics Market Size (2019-2030)
9.2 Latin America Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Evox Therapeutics
11.1.1 Evox Therapeutics Company Details
11.1.2 Evox Therapeutics Business Overview
11.1.3 Evox Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.1.4 Evox Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.1.5 Evox Therapeutics Recent Development
11.2 Carmine Therapeutics
11.2.1 Carmine Therapeutics Company Details
11.2.2 Carmine Therapeutics Business Overview
11.2.3 Carmine Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.2.4 Carmine Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.2.5 Carmine Therapeutics Recent Development
11.3 Exopharm
11.3.1 Exopharm Company Details
11.3.2 Exopharm Business Overview
11.3.3 Exopharm Exosome Therapeutics and Diagnostics Introduction
11.3.4 Exopharm Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.3.5 Exopharm Recent Development
11.4 Aruna Bio
11.4.1 Aruna Bio Company Details
11.4.2 Aruna Bio Business Overview
11.4.3 Aruna Bio Exosome Therapeutics and Diagnostics Introduction
11.4.4 Aruna Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.4.5 Aruna Bio Recent Development
11.5 Capricor Therapeutics
11.5.1 Capricor Therapeutics Company Details
11.5.2 Capricor Therapeutics Business Overview
11.5.3 Capricor Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.5.4 Capricor Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.5.5 Capricor Therapeutics Recent Development
11.6 Mantra Bio
11.6.1 Mantra Bio Company Details
11.6.2 Mantra Bio Business Overview
11.6.3 Mantra Bio Exosome Therapeutics and Diagnostics Introduction
11.6.4 Mantra Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.6.5 Mantra Bio Recent Development
11.7 Adipomics
11.7.1 Adipomics Company Details
11.7.2 Adipomics Business Overview
11.7.3 Adipomics Exosome Therapeutics and Diagnostics Introduction
11.7.4 Adipomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.7.5 Adipomics Recent Development
11.8 ReNeuron
11.8.1 ReNeuron Company Details
11.8.2 ReNeuron Business Overview
11.8.3 ReNeuron Exosome Therapeutics and Diagnostics Introduction
11.8.4 ReNeuron Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.8.5 ReNeuron Recent Development
11.9 Aegle Therapeutics
11.9.1 Aegle Therapeutics Company Details
11.9.2 Aegle Therapeutics Business Overview
11.9.3 Aegle Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.9.4 Aegle Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.9.5 Aegle Therapeutics Recent Development
11.10 Sarepta Therapeutics
11.10.1 Sarepta Therapeutics Company Details
11.10.2 Sarepta Therapeutics Business Overview
11.10.3 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.10.4 Sarepta Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.10.5 Sarepta Therapeutics Recent Development
11.11 Codiak Biosciences
11.11.1 Codiak Biosciences Company Details
11.11.2 Codiak Biosciences Business Overview
11.11.3 Codiak Biosciences Exosome Therapeutics and Diagnostics Introduction
11.11.4 Codiak Biosciences Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.11.5 Codiak Biosciences Recent Development
11.12 Exosomics
11.12.1 Exosomics Company Details
11.12.2 Exosomics Business Overview
11.12.3 Exosomics Exosome Therapeutics and Diagnostics Introduction
11.12.4 Exosomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.12.5 Exosomics Recent Development
11.13 Innocan Pharma
11.13.1 Innocan Pharma Company Details
11.13.2 Innocan Pharma Business Overview
11.13.3 Innocan Pharma Exosome Therapeutics and Diagnostics Introduction
11.13.4 Innocan Pharma Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.13.5 Innocan Pharma Recent Development
11.14 Aethlon Medical
11.14.1 Aethlon Medical Company Details
11.14.2 Aethlon Medical Business Overview
11.14.3 Aethlon Medical Exosome Therapeutics and Diagnostics Introduction
11.14.4 Aethlon Medical Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.14.5 Aethlon Medical Recent Development
11.15 ExoCoBio
11.15.1 ExoCoBio Company Details
11.15.2 ExoCoBio Business Overview
11.15.3 ExoCoBio Exosome Therapeutics and Diagnostics Introduction
11.15.4 ExoCoBio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.15.5 ExoCoBio Recent Development
11.16 Organicell
11.16.1 Organicell Company Details
11.16.2 Organicell Business Overview
11.16.3 Organicell Exosome Therapeutics and Diagnostics Introduction
11.16.4 Organicell Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.16.5 Organicell Recent Development
11.17 Puretech
11.17.1 Puretech Company Details
11.17.2 Puretech Business Overview
11.17.3 Puretech Exosome Therapeutics and Diagnostics Introduction
11.17.4 Puretech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.17.5 Puretech Recent Development
11.18 Versatope
11.18.1 Versatope Company Details
11.18.2 Versatope Business Overview
11.18.3 Versatope Exosome Therapeutics and Diagnostics Introduction
11.18.4 Versatope Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.18.5 Versatope Recent Development
11.19 Vesvigen Therapeutics
11.19.1 Vesvigen Therapeutics Company Details
11.19.2 Vesvigen Therapeutics Business Overview
11.19.3 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.19.4 Vesvigen Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.19.5 Vesvigen Therapeutics Recent Development
11.20 Exosome Plus
11.20.1 Exosome Plus Company Details
11.20.2 Exosome Plus Business Overview
11.20.3 Exosome Plus Exosome Therapeutics and Diagnostics Introduction
11.20.4 Exosome Plus Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.20.5 Exosome Plus Recent Development
11.21 Exosome Diagnostics
11.21.1 Exosome Diagnostics Company Details
11.21.2 Exosome Diagnostics Business Overview
11.21.3 Exosome Diagnostics Exosome Therapeutics and Diagnostics Introduction
11.21.4 Exosome Diagnostics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.21.5 Exosome Diagnostics Recent Development
11.22 ECHO Biaotech
11.22.1 ECHO Biaotech Company Details
11.22.2 ECHO Biaotech Business Overview
11.22.3 ECHO Biaotech Exosome Therapeutics and Diagnostics Introduction
11.22.4 ECHO Biaotech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.22.5 ECHO Biaotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Treatment
Table 3. Key Players of Diagnosis
Table 4. Global Exosome Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Exosome Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Exosome Therapeutics and Diagnostics Market Share by Region (2019-2024)
Table 8. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Exosome Therapeutics and Diagnostics Market Share by Region (2025-2030)
Table 10. Exosome Therapeutics and Diagnostics Market Trends
Table 11. Exosome Therapeutics and Diagnostics Market Drivers
Table 12. Exosome Therapeutics and Diagnostics Market Challenges
Table 13. Exosome Therapeutics and Diagnostics Market Restraints
Table 14. Global Exosome Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Exosome Therapeutics and Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Exosome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics and Diagnostics as of 2023)
Table 17. Ranking of Global Top Exosome Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Exosome Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Exosome Therapeutics and Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Exosome Therapeutics and Diagnostics, Product and Application
Table 21. Global Key Players of Exosome Therapeutics and Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Evox Therapeutics Company Details
Table 47. Evox Therapeutics Business Overview
Table 48. Evox Therapeutics Exosome Therapeutics and Diagnostics Product
Table 49. Evox Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 50. Evox Therapeutics Recent Development
Table 51. Carmine Therapeutics Company Details
Table 52. Carmine Therapeutics Business Overview
Table 53. Carmine Therapeutics Exosome Therapeutics and Diagnostics Product
Table 54. Carmine Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Carmine Therapeutics Recent Development
Table 56. Exopharm Company Details
Table 57. Exopharm Business Overview
Table 58. Exopharm Exosome Therapeutics and Diagnostics Product
Table 59. Exopharm Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Exopharm Recent Development
Table 61. Aruna Bio Company Details
Table 62. Aruna Bio Business Overview
Table 63. Aruna Bio Exosome Therapeutics and Diagnostics Product
Table 64. Aruna Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Aruna Bio Recent Development
Table 66. Capricor Therapeutics Company Details
Table 67. Capricor Therapeutics Business Overview
Table 68. Capricor Therapeutics Exosome Therapeutics and Diagnostics Product
Table 69. Capricor Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Capricor Therapeutics Recent Development
Table 71. Mantra Bio Company Details
Table 72. Mantra Bio Business Overview
Table 73. Mantra Bio Exosome Therapeutics and Diagnostics Product
Table 74. Mantra Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 75. Mantra Bio Recent Development
Table 76. Adipomics Company Details
Table 77. Adipomics Business Overview
Table 78. Adipomics Exosome Therapeutics and Diagnostics Product
Table 79. Adipomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Adipomics Recent Development
Table 81. ReNeuron Company Details
Table 82. ReNeuron Business Overview
Table 83. ReNeuron Exosome Therapeutics and Diagnostics Product
Table 84. ReNeuron Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 85. ReNeuron Recent Development
Table 86. Aegle Therapeutics Company Details
Table 87. Aegle Therapeutics Business Overview
Table 88. Aegle Therapeutics Exosome Therapeutics and Diagnostics Product
Table 89. Aegle Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 90. Aegle Therapeutics Recent Development
Table 91. Sarepta Therapeutics Company Details
Table 92. Sarepta Therapeutics Business Overview
Table 93. Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product
Table 94. Sarepta Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 95. Sarepta Therapeutics Recent Development
Table 96. Codiak Biosciences Company Details
Table 97. Codiak Biosciences Business Overview
Table 98. Codiak Biosciences Exosome Therapeutics and Diagnostics Product
Table 99. Codiak Biosciences Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 100. Codiak Biosciences Recent Development
Table 101. Exosomics Company Details
Table 102. Exosomics Business Overview
Table 103. Exosomics Exosome Therapeutics and Diagnostics Product
Table 104. Exosomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 105. Exosomics Recent Development
Table 106. Innocan Pharma Company Details
Table 107. Innocan Pharma Business Overview
Table 108. Innocan Pharma Exosome Therapeutics and Diagnostics Product
Table 109. Innocan Pharma Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 110. Innocan Pharma Recent Development
Table 111. Aethlon Medical Company Details
Table 112. Aethlon Medical Business Overview
Table 113. Aethlon Medical Exosome Therapeutics and Diagnostics Product
Table 114. Aethlon Medical Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 115. Aethlon Medical Recent Development
Table 116. ExoCoBio Company Details
Table 117. ExoCoBio Business Overview
Table 118. ExoCoBio Exosome Therapeutics and Diagnostics Product
Table 119. ExoCoBio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 120. ExoCoBio Recent Development
Table 121. Organicell Company Details
Table 122. Organicell Business Overview
Table 123. Organicell Exosome Therapeutics and Diagnostics Product
Table 124. Organicell Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 125. Organicell Recent Development
Table 126. Puretech Company Details
Table 127. Puretech Business Overview
Table 128. Puretech Exosome Therapeutics and Diagnostics Product
Table 129. Puretech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 130. Puretech Recent Development
Table 131. Versatope Company Details
Table 132. Versatope Business Overview
Table 133. Versatope Exosome Therapeutics and Diagnostics Product
Table 134. Versatope Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 135. Versatope Recent Development
Table 136. Vesvigen Therapeutics Company Details
Table 137. Vesvigen Therapeutics Business Overview
Table 138. Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product
Table 139. Vesvigen Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 140. Vesvigen Therapeutics Recent Development
Table 141. Exosome Plus Company Details
Table 142. Exosome Plus Business Overview
Table 143. Exosome Plus Exosome Therapeutics and Diagnostics Product
Table 144. Exosome Plus Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 145. Exosome Plus Recent Development
Table 146. Exosome Diagnostics Company Details
Table 147. Exosome Diagnostics Business Overview
Table 148. Exosome Diagnostics Exosome Therapeutics and Diagnostics Product
Table 149. Exosome Diagnostics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 150. Exosome Diagnostics Recent Development
Table 151. ECHO Biaotech Company Details
Table 152. ECHO Biaotech Business Overview
Table 153. ECHO Biaotech Exosome Therapeutics and Diagnostics Product
Table 154. ECHO Biaotech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 155. ECHO Biaotech Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report


List of Figures
Figure 1. Exosome Therapeutics and Diagnostics Picture
Figure 2. Global Exosome Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Exosome Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030
Figure 4. Treatment Features
Figure 5. Diagnosis Features
Figure 6. Global Exosome Therapeutics and Diagnostics Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Exosome Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030
Figure 8. Cancer Case Studies
Figure 9. Neurological Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Exosome Therapeutics and Diagnostics Report Years Considered
Figure 12. Global Exosome Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Exosome Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Exosome Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030
Figure 15. Global Exosome Therapeutics and Diagnostics Market Share by Players in 2023
Figure 16. Global Top Exosome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics and Diagnostics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Exosome Therapeutics and Diagnostics Revenue in 2023
Figure 18. North America Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 20. United States Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 24. Germany Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Exosome Therapeutics and Diagnostics Market Share by Region (2019-2030)
Figure 32. China Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 40. Mexico Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 44. Turkey Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Evox Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 48. Carmine Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 49. Exopharm Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 50. Aruna Bio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 51. Capricor Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 52. Mantra Bio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 53. Adipomics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 54. ReNeuron Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 55. Aegle Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 56. Sarepta Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 57. Codiak Biosciences Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 58. Exosomics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 59. Innocan Pharma Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 60. Aethlon Medical Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 61. ExoCoBio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 62. Organicell Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 63. Puretech Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 64. Versatope Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 65. Vesvigen Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 66. Exosome Plus Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 67. Exosome Diagnostics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 68. ECHO Biaotech Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock